First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters was written by Hernandez-Olmos, Victor;Heering, Jan;Planz, Viktoria;Liu, Ting;Kaps, Alexander;Rajkumar, Rinusha;Gramzow, Matthias;Kaiser, Astrid;Schubert-Zsilavecz, Manfred;Parnham, Michael J.;Windbergs, Maike;Steinhilber, Dieter;Proschak, Ewgenij. And the article was included in Journal of Medicinal Chemistry in 2020.Product Details of 653-92-9 This article mentions the following:
The first potent leukotriene B4 (LTB4) receptor type 2 (BLT2) agonists, endogenous 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT), and synthetic CAY10583 (CAY) have been recently described to accelerate wound healing by enhanced keratinocyte migration and indirect stimulation of fibroblast activity in diabetic rats. CAY represents a very valuable starting point for the development of novel wound-healing promoters. In this work, the first structure-activity relationship study for CAY scaffold-based BLT2 agonists is presented. The newly prepared derivatives showed promising in vitro wound-healing activity. In the experiment, the researchers used many compounds, for example, Methyl 2-bromo-4-fluorobenzoate (cas: 653-92-9Product Details of 653-92-9).
Methyl 2-bromo-4-fluorobenzoate (cas: 653-92-9) belongs to organobromine compounds. Organo bromine compounds are versatile compounds and are widely used in diverse fields. Organo bromine derivatives are used in the dye sector, as an indicator in analytical chemistry (Bromothymol blue is a popular indicator). Many of the alkyl bromine derivatives are excellent alkylating agents since bromides are good leaving groups. Tribromides, like tetrabutylammonium tribromide, are used as a solid source of bromine. N-bromosuccimide (NBS) is used for the selective bromination of allylic bonds.Product Details of 653-92-9
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary